Target intelligence / Profile preview

Blood deficiency

Molecular classification
Other (not a molecular target, but a clinical condition)
01

Overview

"Blood deficiency" is not the name of any recognized therapeutic target, receptor, enzyme, transporter, or gene. Instead, it is an outdated or non-specific term most commonly referring to anemia, which is defined as having too few red blood cells or too little hemoglobin in the blood. Anemia itself is a clinical syndrome with many possible causes—including nutritional deficiencies (iron, vitamin B12), genetic disorders (thalassemia), chronic diseases (kidney disease), and more—but it does not refer to any single molecule or druggable biological entity[1][3][5]. Therefore, "blood deficiency" should not be considered as an individual therapeutic target.

Other names
Blood deficiencyAnemia (most common clinical term)
02

Mechanism of action

Not applicable as "blood deficiency" is not a molecular target. Mechanisms relate to correcting underlying causes of anemia—e.g., iron supplementation increases hemoglobin synthesis.[1]

03

Biological functions

Other (refers to a physiological state, not a specific molecule or protein)
04

Disease associations

Other (clinical syndrome; can be secondary to many diseases such as cancer, infection, chronic disease)
05

Safety considerations

Not applicable at the molecular target level. Safety concerns relate to treatment side effects and underlying causes of anemia.[9]
06

Interacting drugs

Iron supplements

3 more in the full profile.

07

Biomarkers

Hemoglobin concentrationHematocrit

Beyond the preview

Go deeper on Blood deficiency.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood deficiency.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call